Privia Health Group, Inc. (PRVA)

From the record

Privia Health Group, Inc.'s filings since 2019 show no warning events in the scan: no bankruptcy or receivership notice, no debt default notice, no exchange listing notice, no restatement warning, no auditor change, no material cyber incident and no late-report notice (its current reports).

From the record

Privia Health Group, Inc.'s 7 filed years say what it did: revenue went from $786 million in fiscal 2019 to $2.1 billion in fiscal 2025, up 18% a year; it rose in 6 of 6 years; it never fell from a peak; net income was positive in 5 of 7 of those years (its annual reports).

From the record

Over the 3 fiscal years to 2025-12-31, Privia Health Group, Inc.'s diluted share count grew about 5.2% a year, and dividends and buybacks returned about 0% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 40 sales (28 under scheduled 10b5-1 plans) and 0 purchases of their own stock on the open market in the year to 2026-09-30 (their Form 4 filings).

From the record

Return on equity: in the fiscal year ended 2025-12-31, Privia Health Group, Inc. earned about 3 cents of profit for every dollar of shareholders' money. Leverage: it owed about 42 cents per dollar of assets, and net share issuance: its share count grew 2.6% over the year (the filed statements).

From the record

Privia Health Group, Inc.'s standing among 14 graded names in its industry family: revenue of $2.1 billion in fiscal 2025 ranks in the top 4% by size; a net margin of 1.1% ranks in the top 32%; revenue growth of 16.1% a year over the last 3 filed years ranks in the bottom 46% (its annual reports).

From the record

Privia Health Group, Inc.'s leadership, from its insiders' filings and its current reports: the chief executive on the record is Mehrotra, Parth (Chief Executive Officer, as filed), filing under that title since 2023-07-21, 3.3 years (top 35% of its family); the 12 officers and directors filing in the last fifteen months have been on the record a median of 5 years (top 50%); 6 officer or director changes were reported on Form 8-K since 2023-11-13, against the 12 people in charge now (bottom 25%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

From the record

Privia Health Group, Inc.'s room to grow, from the newest filed statements (fiscal 2025): cash of $480 million against no long-term debt tagged leaves 35% of its assets as net cash, top 11% of its family; cash from operations less capital spending is 7.7% of revenue (top 25%) (its annual report).

From the record

Privia Health Group, Inc.'s growth drivers, from the filed years to fiscal 2025: revenue grew 16.1% a year over the last three filed years against 18% over all 7, slowing (bottom 46% of its family); the newest year grew 22.3% (top 46%); capital spending grew -33.3% a year (bottom 4%) (its annual reports). Privia Health Group, Inc. reported 7 product lines in fiscal 2025: FFS Patient Care at $1.4 billion (64%), Capitated Revenue at $308 million (14%), Shared Savings at $235 million (11%), and 4 more; 7 of 7 grew against the year before (its annual report).

From the record

Privia Health Group, Inc.'s newest year against its own record: revenue of $2.1 billion in fiscal 2025 came in 8.1% above the $2.0 billion its prior three years' pace pointed to (top 46% of its family); net income of $23 million against a prior three-year average of $10 million (top 12%); a net margin of 1.1% against 0.5% before (bottom 29%) (its annual reports).